Can efavirenz be taken in the morning?

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 11-12, 2006, Pages 1089-1091

  Skeie, Linda ^a   Maeland, Arild ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; EFAVIRENZ; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DREAM; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL CONCENTRATION; PATIENT COMPLIANCE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHIFT WORKER; SIDE EFFECT;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OXAZINES; PATIENT COMPLIANCE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 33845333856     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600794386     Document Type: Article

References (4)

1. Moyle G, the APPT-1 Study Team. The Assessing Patients' Preferred Treatments (APTT-1) study. Int J of STD & AIDS 2003;14(Suppl 1):34-6.
2. Weber, R and Christen, L and Christen, S and Tschopp, S and Znoj, H and Schneider, C and (2004) Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: Prospective randomized trial Antivir Ther, 9, pp. 85-95.
3. Staszewski, S and Morales-Ramirez, J and Tashima, KT and Rachlis, A and Skiest, D and Stanford, J and (1999) Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults N Engl J Med, 341, pp. 1865-73.
4. Haas, D and Ribaudo, H and Kim, RB and Tierney, C and Wilkinson, GR and Gulick, R and (2004) Pharmacogenetics of efavirenz and central nervous system side-effects: An Adult AIDS Clinical Trials Group study AIDS, 18, pp. 2391-400.